Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Hum Gene Ther ; 8(10): 1231-41, 1997 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-9215740

RESUMEN

Gene delivery via murine-based recombinant retroviral vectors is currently widely used in gene therapy clinical trials. The vectors are engineered to be replication defective by replacing the structural and nonstructural genes of a cloned infectious retrovirus with a therapeutic gene of interest. The retroviral particles are currently generated in packaging cell lines, which supply all retroviral proteins in trans. Recombination between short homologous regions of the retroviral vector and packaging cell line elements can theoretically generate replication-competent retrovirus (RCR) and hence the Food and Drug Administration (FDA) requires the monitoring of clinical trial subjects for the presence of RCR. Sensitive polymerase chain reaction (PCR) assays have been used for the detection of murine leukemia virus (MLV) nucleotide sequences in peripheral blood mononuclear cells (PBMCs). A novel serological enzyme-linked immunosorbent assay (ELISA) for the detection of anti-MLV specific immunoglobulin (Ig) has been developed to be used as an alternative to the PCR assay. Both assays were used to monitor human immunodeficiency virus (HIV)-positive clinical trial subjects who had received multiple injections of HIV-IT (V), a retroviral vector encoding HIV-1 IIIBenv/rev. Western blot analysis and an in vitro vector neutralization assay were used to characterize further a subset of serum samples tested by ELISA. Results show no evidence of RCR infection in clinical trial subjects. PCR and ELISA assays are discussed in terms of their advantages and limitations as routine screening assays for RCR. The PCR assay is our current choice for monitoring clinical trial subjects receiving direct administration of vector, and the ELISA is our choice for those receiving ex vivo treatment regimens.


Asunto(s)
Ensayo de Inmunoadsorción Enzimática/métodos , Vectores Genéticos/uso terapéutico , Reacción en Cadena de la Polimerasa/métodos , Retroviridae/genética , Anticuerpos Antivirales/análisis , Anticuerpos Antivirales/sangre , Ensayos Clínicos Fase I como Asunto , Estudios de Evaluación como Asunto , Vectores Genéticos/genética , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/genética , Infecciones por VIH/virología , Humanos , Virus de la Leucemia Murina/genética , Virus de la Leucemia Murina/inmunología , Replicación Viral
2.
Plant Mol Biol ; 25(3): 387-99, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8049365

RESUMEN

Genomic clones encoding two isozymes of aspartate aminotransferase (AAT) were isolated from an alfalfa genomic library and their DNA sequences were determined. The AAT1 gene contains 12 exons that encode a cytosolic protein expressed at similar levels in roots, stems and nodules. In nodules, the amount of AAT1 mRNA was similar at all stages of development, and was slightly reduced in nodules incapable of fixing nitrogen. The AAT1 mRNA is polyadenylated at multiple sites differing by more than 250 bp. The AAT2 gene contains 11 exons, with 5 introns located in positions identical to those found in animal AAT genes, and encodes a plastid-localized isozyme. The AAT2 mRNA is polyadenylated at a very limited range of sites. The transit peptide of AAT2 is encoded by the first two and part of the third exon. AAT2 mRNA is much more abundant in nodules than in other organs, and increases dramatically during the course of nodule development. Unlike AAT1, expression of AAT2 is significantly reduced in nodules incapable of fixing nitrogen. Phylogenetic analysis of deduced AAT proteins revealed 4 separate but related groups of AAT proteins; the animal cytosolic AATs, the plant cytosolic AATs, the plant plastid AATs, and the mitochondrial AATs.


Asunto(s)
Aspartato Aminotransferasas/genética , Genes de Plantas/genética , Isoenzimas/genética , Medicago sativa/genética , Secuencia de Aminoácidos , Secuencia de Bases , Evolución Biológica , Compartimento Celular , Clonación Molecular , Citoplasma/enzimología , Medicago sativa/enzimología , Datos de Secuencia Molecular , Plastidios/enzimología , ARN Mensajero/análisis , Análisis de Secuencia de ADN , Distribución Tisular
3.
Mol Gen Genet ; 241(1-2): 124-8, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8232195

RESUMEN

Aspartate aminotransferase (AAT) plays a key enzymatic role in the assimilation of symbiotically fixed nitrogen in legume root nodules. In alfalfa, two distinct genetic loci encode dimeric AAT enzymes: AAT1, which predominates in roots, and AAT2, which is expressed at high levels in nodules. Three allozymes of AAT2 (AAT2a, -2b and -2c), differing in net charge, result from the expression of two alleles, AAT2A and AAT2C, at this locus. Utilizing antiserum to alfalfa AAT2, we have previously isolated from an expression library one AAT2 cDNA clone. This clone was used as a hybridization probe to screen cDNA libraries for additional AAT2 cDNAs. Four different clones were obtained, two each that encode the AAT2a and AAT2c enzyme subunits. These two sets of cDNAs encode polypeptides that differ in net charge depending upon the amino acid at position 296 (valine or glutamic acid). Within each set of alleles, the two members differ from each other by the presence or absence of a 30 bp (ten amino acid) sequence. The presence or absence of this ten amino acid sequence has no effect on the size or charge of the mature AAT2 protein because it is located within the region encoding the protein's transit peptide, which is proteolytically removed upon transport into plastids. The data suggest that a deletion event has occurred independently in two AAT2 progenitor alleles, resulting in the four allelic cDNA variants observed. The deletion of this ten amino acid sequence does not appear to impair the normal maturation of the enzyme.


Asunto(s)
Alelos , Aspartato Aminotransferasas/genética , Medicago sativa/genética , Polimorfismo Genético , Secuencia de Aminoácidos , Secuencia de Bases , ADN Complementario , Homocigoto , Medicago sativa/enzimología , Datos de Secuencia Molecular , Fijación del Nitrógeno/genética , Alineación de Secuencia
4.
Biol Reprod ; 49(2): 295-9, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8373952

RESUMEN

We have investigated the effects of ovariectomy (OVX) and photostimulation (PS) on anterior pituitary LH beta mRNA abundance and circulating levels of LH in the domestic turkey. The birds were divided into the following four treatment groups: non-PS SHAM, PS SHAM, non-PS OVX, and PS OVX. Photostimulation was initiated 7 days after OVX. Anterior pituitaries and blood samples were collected on Days 0, 1, 3, 7, 14, and 26 after PS. The experiment was terminated when the PS SHAM birds were laying eggs regularly. Photostimulation of intact birds induced an increase in both LH beta mRNA levels (Days 3, 14, and 26 of PS) and serum LH (Days 14 and 26 of PS; p < 0.05), while OVX of non-PS birds significantly elevated LH on Days 7, 10, 21, and 33 and LH beta mRNA levels on Days 7, 8, 10, 14, and 33 post-OVX. Circulating LH titers in the PS OVX birds were well above the levels in the non-PS OVX group (p < 0.005); however, LH beta mRNA abundance was not significantly greater (p > 0.05). Our results indicate that OVX and PS appear to be additive in stimulating LH secretion but do not have this effect on LH beta mRNA levels. We have hypothesized that gonadectomy induces near-maximal accumulation of LH beta mRNA and that therefore the subsequent stimulus of a long photoperiod has no additional effect. We suggest that increases in serum LH levels, beyond those of the OVX bird, may be controlled post-transcriptionally.


Asunto(s)
Regulación de la Expresión Génica , Luz , Hormona Luteinizante/genética , Hormona Luteinizante/metabolismo , Ovariectomía , Pavos/fisiología , Animales , Femenino , Fotoperiodo , Adenohipófisis/fisiología , ARN Mensajero/metabolismo , Pavos/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA